Your browser doesn't support javascript.
loading
Clinical and Safety Outcomes of Endovascular Therapy 6 to 24 Hours After Large Vessel Occlusion Ischemic Stroke With Tandem Lesions.
Galecio-Castillo, Milagros; Farooqui, Mudassir; Hassan, Ameer E; Jumaa, Mouhammad A; Divani, Afshin A; Ribo, Marc; Abraham, Michael; Petersen, Nils H; Fifi, Johanna T; Guerrero, Waldo R; Malik, Amer M; Siegler, James E; Nguyen, Thanh N; Sheth, Sunil; Yoo, Albert J; Linares, Guillermo; Janjua, Nazli; Quispe-Orozco, Darko; Tekle, Wondwossen; Zaidi, Syed F; Sabbagh, Sara Y; Olivé-Gadea, Marta; Barkley, Tiffany; Leacy, Reade De; Sprankle, Kenyon W; Abdalkader, Mohamad; Salazar-Marioni, Sergio; Soomro, Jazba; Gordon, Weston; Turabova, Charoskhon; Vivanco-Suarez, Juan; Rodriguez-Calienes, Aaron; Mokin, Maxim; Yavagal, Dileep R; Jovin, Tudor; Ortega-Gutierrez, Santiago.
Afiliación
  • Galecio-Castillo M; Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
  • Farooqui M; Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
  • Hassan AE; Department of Neurology, Valley Baptist Medical Center/University of Texas Rio Grande Valley, Harlingen, TX, USA.
  • Jumaa MA; Department of Neurology, ProMedica Toledo Hospital, Toledo, OH, USA.
  • Divani AA; Department of Neurology, University of New Mexico Health Science Center, Albuquerque, NM, USA.
  • Ribo M; Department of Neurology, Hospital Vall d'Hebron, Barcelona, Spain.
  • Abraham M; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.
  • Petersen NH; Department of Neurology, Yale University School of Medicine, New Haven, CT, USA.
  • Fifi JT; Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Guerrero WR; Department of Neurology and Brain Repair, University of South Florida, Tampa, FL, USA.
  • Malik AM; Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Siegler JE; Cooper Neurological Institute, Cooper University Hospital, Camden, NJ, USA.
  • Nguyen TN; Cooper Medical School of Rowan University, Camden, NJ, USA.
  • Sheth S; Department of Neurology, Boston Medical Center, Boston, MA, USA.
  • Yoo AJ; Department of Neurology, UT Health McGovern Medical School, Houston, TX, USA.
  • Linares G; Texas Stroke Institute, Dallas-Fort Worth, TX, USA.
  • Janjua N; Department of Neurology, Saint Louis University, St. Louis, MO, USA.
  • Quispe-Orozco D; Asia Pacific Comprehensive Stroke Institute, Pomona Valley Hospital Medical Center, Pomona, CA, USA.
  • Tekle W; Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
  • Zaidi SF; Department of Neurology, Valley Baptist Medical Center/University of Texas Rio Grande Valley, Harlingen, TX, USA.
  • Sabbagh SY; Department of Neurology, ProMedica Toledo Hospital, Toledo, OH, USA.
  • Olivé-Gadea M; Department of Neurology, University of New Mexico Health Science Center, Albuquerque, NM, USA.
  • Barkley T; Department of Neurology, Hospital Vall d'Hebron, Barcelona, Spain.
  • Leacy R; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.
  • Sprankle KW; Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Abdalkader M; Cooper Medical School of Rowan University, Camden, NJ, USA.
  • Salazar-Marioni S; Department of Radiology, Boston Medical Center, Boston, MA, USA.
  • Soomro J; Department of Neurology, UT Health McGovern Medical School, Houston, TX, USA.
  • Gordon W; Texas Stroke Institute, Dallas-Fort Worth, TX, USA.
  • Turabova C; Department of Neurology, Saint Louis University, St. Louis, MO, USA.
  • Vivanco-Suarez J; Asia Pacific Comprehensive Stroke Institute, Pomona Valley Hospital Medical Center, Pomona, CA, USA.
  • Rodriguez-Calienes A; Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
  • Mokin M; Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
  • Yavagal DR; Department of Neurology and Brain Repair, University of South Florida, Tampa, FL, USA.
  • Jovin T; Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Ortega-Gutierrez S; Cooper Neurological Institute, Cooper University Hospital, Camden, NJ, USA.
J Stroke ; 25(3): 378-387, 2023 Sep.
Article en En | MEDLINE | ID: mdl-37607694
BACKGROUND AND PURPOSE: Effect of endovascular therapy (EVT) in acute large vessel occlusion (LVO) patients with tandem lesions (TLs) within 6-24 hours after last known well (LKW) remains unclear. We evaluated the clinical and safety outcomes among TL-LVO patients treated within 6-24 hours. METHODS: This multicenter cohort was divided into two groups, based on LKW to puncture time: early window (<6 hours), and late window (6-24 hours). Primary clinical and safety outcomes were 90-day functional independence measured by the modified Rankin Scale (mRS: 0-2) and symptomatic intracranial hemorrhage (sICH). Secondary outcomes were successful reperfusion (modified Thrombolysis in Cerebral Infarction score ≥2b), first-pass effect, early neurological improvement, ordinal mRS, and in-hospital and 90-day mortality. RESULTS: Of 579 patients (median age 68, 32.1% females), 268 (46.3%) were treated in the late window and 311 (53.7%) in the early window. Late window group had lower median National Institutes of Health Stroke Scale score at admission, Alberta Stroke Program Early Computed Tomography Score, rates of intravenous thrombolysis, and higher rates for perfusion imaging. After adjusting for confounders, the odds of 90-day mRS 0-2 (47.7% vs. 45.0%, adjusted odds ratio [aOR] 0.71, 95% confidence interval [CI] 0.49-1.02), favorable shift in mRS (aOR 0.88, 95% CI 0.44-1.76), and sICH (3.7% vs. 5.2%, aOR 0.56, 95% CI 0.20-1.56) were similar in both groups. There was no difference in secondary outcomes. Increased time from LKW to puncture did not predicted the probability of 90-day mRS 0-2 (aOR 0.99, 95% CI 0.96-1.01, for each hour delay) among patients presenting <24 hours. CONCLUSION: EVT for acute TL-LVO treated within 6-24 hours after LKW was associated with similar rates of clinical and safety outcomes, compared to patients treated within 6 hours.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Stroke Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Stroke Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos